Article Details

Russian drugmakers bypass Gilead to unveil COVID-19 generic

Retrieved on: 2021-02-04 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Russian drugmakers bypass Gilead to unveil COVID-19 generic. View article details on hiswai:

Excerpt

Remdesivir is marketed by Gilead under its Veklury brand, and was approved by the US Food and Drug Administration in November. This latest ...

Article found on: www.lifesciencesipreview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo